rTMS for Epilepsy: What a Review Found About Short-Term Seizure Reduction
Researchers systematically reviewed 14 randomized controlled trials involving 516 adults with epilepsy, including adults with drug-resistant focal epilepsy.
Researchers systematically reviewed 14 randomized controlled trials involving 516 adults with epilepsy, including adults with drug-resistant focal epilepsy.
This systematic review and meta-analysis compared two procedures for drug-resistant epilepsy caused by MRI-positive focal cortical dysplasia type II (FCD II) or tuberous sclerosis complex (TSC).
Researchers combined results from 12 citations on brivaracetam use in children and adolescents age 18 or younger with epilepsy.
This systematic review examined whether déjà vu, déjà vécu, dreamy states, and reminiscence during focal seizures can help identify the epileptogenic zone.
This multicenter retrospective study reviewed clinical records from 61 people with genetically confirmed Dravet syndrome.
Researchers reviewed records from 163 adults treated at one Danish hospital from 2008 to 2017.
Researchers combined results from 48 studies involving 822 people with Lennox-Gastaut syndrome across 19 countries.
This systematic review and meta-analysis examined neuromodulation treatments for people younger than 18 years with drug-resistant epilepsy.
Researchers reviewed records from 93 children with febrile status epilepticus admitted to one hospital between January 2020 and April 2023.